本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NovaBay Pharmaceuticals Inc

5.43
+0.13002.45%
盤前5.15-0.2800-5.16%08:49 EST
成交量:240.32萬
成交額:1,366.25萬
市值:6.84億
市盈率:11.64
高:6.23
開:5.36
低:4.97
收:5.30
52周最高:6.47
52周最低:0.4600
股本:1.26億
流通股本:498.48萬
量比:0.35
換手率:48.21%
股息:- -
股息率:- -
每股收益(TTM):0.4666
每股收益(LYR):-2.5347
淨資產收益率:-516.26%
總資產收益率:-86.98%
市淨率:-255.03
市盈率(LYR):-2.14

資料載入中...

2024/11/22

重要事件披露

Form 8-K - Current report
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/10/29

重要事件披露

Form 8-K - Current report
2024/10/16

重要事件披露

Form 8-K - Current report
2024/09/20

重要事件披露

Form 8-K - Current report
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/30

重要事件披露

Form 8-K - Current report
2024/07/25

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/07/23

SEC問詢函

Form CORRESP - Correspondence
2024/07/23

SEC問詢函

Form CORRESP - Correspondence
2024/07/13

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/07/11

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/07/11

重要事件披露

Form 8-K - Current report
2024/07/10

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/07/10

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/26

SEC問詢函

Form CORRESP - Correspondence
2024/06/21

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/21

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans